Audio
Baker McKenzie | European Union, Mexico, USA | 21 Oct 2020
The Health Pod, Baker McKenzie's industry podcast series, highlights sector-specific issues and trends that affect healthcare and life sciences…
Article
Bereskin & Parr LLP | Canada | 7 Jul 2020
Repurposing existing or abandoned drugs is an attractive route to finding a treatment and cure for COVID-19 quickly. To initiate such efforts, the…
Article
Ropes & Gray LLP | Australia, Brazil, Canada, etc. | 8 Apr 2020
The COVID-19 pandemic has had a major impact on the conduct of clinical trials worldwide. Recognizing this impact, National authorities have issued…
Article
Keller and Heckman LLP | USA | 10 Mar 2020
In a March 9 email to stakeholders, Health Canada’s Food Directorate requested data in regard to food additives in certain food flavouring…
Article
Fasken | Canada | 30 Jan 2020
The World Health Organization (WHO) has declared the 2019 Novel Coronavirus outbreak a public health emergency of international concern. There are…
Article
Smart & Biggar | Canada | 29 Jan 2020
There have been a number of key developments in Canadian life sciences IP and regulatory law over the past 12 months, including significant amendments…
Article
Fasken | Canada | 12 Dec 2019
The cannabis market is currently experiencing some turbulence and uncertainty, but that market and underlying consumer demand is well established. As…
Article
Smart & Biggar | Canada | 23 Oct 2019
The certificate of supplementary protection (CSP) regime recently celebrated its second anniversary. This article looks back on the previous year and…
Article
Bereskin & Parr LLP | Canada | 23 Oct 2019
Although recreational cannabis was legalized in Canada in October 2018, legalization was restricted to specific products such as dried cannabis, oils…
Article
Fasken | Canada | 23 Oct 2019
With the Liberal Party of Canada ("Liberal Party") winning Monday's Federal Election with 157 of 338 seats in the House of Commons, campaign promises…